Lupin expands its presence across India

Global pharma major Lupin Limited announced that Lupin Diagnostics has launched its Regional Reference Laboratory in Assam, Guwahati in North East India. It is a part of the Lupin Diagnostics’ strategy to expand its presence across India and increase access to quality testing.

It has capabilities to conduct a broad spectrum of routine and specialized tests in the fields of molecular diagnostics, cytogenetics, flow cytometry, histopathology, cytology, microbiology, serology, hematology, immunology and routine biochemistry. It offers a comprehensive range of diagnostics services to doctors, patients and consumers. Some of its key consumer-centric features are GPS-enabled, temperature-controlled sample movement, smart reports, NABL accreditation of each laboratory, trend report analysis and live home collection booking and tracking.
After Assam and West Bengal, Lupin Diagnostics is also setting up laboratories in Patna (Bihar), Ranchi (Jharkhand) and Bhubaneshwar (Orissa), in addition to multiple cities across West Bengal to comprehensively cater to the Eastern region of India.

These labs will be connected to Lupin’s franchise collection centers LupiMitra. It has more than 250 LupiMitra enrolled across the country. The company started its journey by establishing a 45,000 square foot National Reference Laboratory in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols.
The Vice President and Head of Lupin Diagnostics Mr. Ravindra Kumar said, “We believe that access to accurate and affordable diagnostic services is a necessity across the country. Hence we are pleased to announce our expansion in the North-Eastern regions of India.”